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Brief Summary: We describe the isolation of vaccine-like poliovirus in sewage samples using 20 
concentration methods followed by cell culture infection and next generation sequencing. 21 
Using this approach, we rapidly obtained whole-genome sequences of polio and non-polio 22 
enterovirus strains present in mixtures. 23 
 24 
 25 
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ABSTRACT 26 
Background: 27 
Environmental surveillance (ES) is a sensitive method for detecting human enterovirus 28 
(HEV) circulation and it is used worldwide to support global polio eradication. We describe a 29 
novel ES approach using next generation sequencing (NGS) to identify HEVs in sewage 30 
samples taken in London, UK, from June-2016 to May-2017.    31 
Methods and Results: 32 
Two different sewage concentration methods were used: a two-phase aqueous separation 33 
system and size-exclusion by filtration and centrifugation, in combination with virus isolation 34 
in cell cultures and NGS. Type 1 and 3 vaccine-like poliovirus (PV) strains were detected in 35 
samples from September 2016 and January 2017. NGS analysis allowed us to rapidly obtain 36 
whole-genome sequences of polio and non-polio HEV strains. As many as six virus strains 37 
from different HEV serotypes were identified in a single cell culture flask. PV isolates 38 
contained only a small number of mutations from vaccine strains commonly seen in early 39 
isolates from vaccinees.  40 
Conclusions: 41 
Our ES setup has high sensitivity for polio and non-polio HEV detection generating nearly 42 
whole-genome sequence information. Such ES systems provide critical information to assist 43 
the polio eradication endgame and contribute to improve our understanding of HEV 44 
circulation patterns in humans.  45 
 46 
 47 
 48 
 49 
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INTRODUCTION 51 
The Global Polio Eradication Initiative (GPEI) has been very successful in reducing PV 52 
circulation in humans to the brink of global extinction [1]. However, some areas in 53 
Afghanistan and Pakistan remain where PV transmission has never been eliminated and type 54 
1 wild PV (WPV1) and type 2 circulating vaccine-derived PV (cVDPV2) are still being 55 
transmitted from person to person. In addition, as of July 2017, PV transmission still occurs 56 
in some areas of the Middle East and Africa where there are severe difficulties in accessing 57 
children for vaccination.  WPV1 was last detected in Nigeria in September 2016 and recent 58 
cVDPV2 outbreaks have been reported in Syria and DR Congo [2, 3].  59 
As only a small proportion of infections by PV cause paralytic disease, the 60 
establishment of efficient and sensitive surveillance systems to guide public health 61 
interventions has been essential in ensuring the GPEI success. The GPEI mostly relies on 62 
acute flaccid paralysis (AFP) surveillance which is monitored by strict quality performance 63 
indicators [4, 5]. A WHO global polio laboratory network of more than 140 laboratories 64 
exists where stool samples from AFP cases are processed and analysed for the presence of 65 
PV.  In addition, several countries have successfully conducted ES for PV for many years. 66 
Virus genotypes of isolates found in sewage samples from Egypt, Nigeria, India, Afghanistan 67 
and Pakistan closely matched those found in stool samples from AFP cases which has helped 68 
tracing the elimination of wild PV in some areas [6-9]. This approach has also been used to 69 
monitor the disappearance of vaccine virus after vaccination campaigns in countries such as 70 
Cuba, New Zealand and Japan [10-12]. Furthermore, widespread circulation of WPV1 71 
imported from Pakistan, in the absence of reported paralytic cases, was identified in Israel in 72 
2013 as the virus was found in sewage samples across the country clearly suggesting that PV 73 
can circulate for long periods of time undetected in countries using IPV, even in those with 74 
high vaccination coverage such as Israel [13, 14]. Thus, ES is seen as a powerful tool to 75 
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support the GPEI endgame helping to identify any remaining PV transmission. With this in 76 
mind, a pilot study was set up to analyse sewage samples from London for the presence of 77 
PV. The last polio case due to wild PV in the UK was reported in 1982, but the country 78 
switched to the exclusive use of IPV in 2004 and has frequent population exchanges with 79 
areas where PV is still circulating and/or OPV is being used routinely. We concentrated 80 
sewage samples using two different methods and added them to cell cultures susceptible for 81 
HEV infection. HEV isolates were then characterised by nucleotide sequencing. Nucleotide 82 
sequence information of HEV clinical and environmental isolates is limited, often restricted 83 
to HEV species-specific real-time PCR positive/negative results and/or short genomic 84 
sequences that can help identifying the HEV serotype but have limited use for detailed 85 
phylogenetic analysis. NGS metagenomics and target-specific techniques have recently been 86 
described by us and others to obtain nucleotide sequences of HEV strains present in stool, 87 
sewage and cell culture samples [15-21]. A novel approach using NGS analysis is described 88 
here to quickly obtain nearly whole-genome sequences of polio and non-polio HEVs present 89 
in cell cultures infected with sewage concentrates. This approach has the power to detect 90 
known HEVs as well as divergent strains and novel serotypes providing information that 91 
should assist with tracing the source and transmission of HEVs, including PV, in human 92 
populations. 93 
 94 
MATERIALS AND METHODS 95 
Sample collection 96 
One litre composite sewage samples were collected during a 24-hour period once monthly at 97 
Beckton Sewage Treatment Works in London (UK), currently treating the waste of 3.5 98 
million people. Samples were transported to the laboratory on the same day and processed 99 
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within one day of arrival. A total of twelve samples were collected from June 2016 to May 100 
2017.  101 
 102 
Sample processing 103 
Raw sewage samples were processed by two different methods previously described: two-104 
phase (TP) aqueous separation system  [22] and concentration by filtration and centrifugation 105 
(FC) using Centriprep® YM-50 centrifugal concentration devices (Merck) [23].  106 
 107 
Cell lines and Virus Isolation 108 
Virus isolation in cell cultures was performed according to WHO recommendations [24]. 109 
Rhabdomyosarcoma (RD) and mouse L20B cells expressing the human PV receptor were 110 
used as detailed in the Supplementary Data section 111 
 112 
Intratypic differentiation (ITD) of PV isolates by real-time RT-PCR (rRT-PCR) assays. 113 
Conventional PV ITD rRT-PCR was performed using a PV diagnostic rRT-PCR kit provided 114 
by the US CDC using a Rotorgene Q (Qiagen) platform and following kit instructions [25].  115 
 116 
Nucleotide sequence analysis of the VP1 coding region of PV isolates. 117 
RT-PCR fragments containing the VP1 coding region were generated from purified viral 118 
RNAs by one-step RT-PCR using a SuperScript III (Invitrogen) system and primers Y7 (5′-119 
GGGTTTGTGTCAGCCTGTAATGA-3′) and Q8 (5′-AAGAGGTCTCTRTTCCACAT-3′) 120 
[25]. Amplified products were purified using QIAquick Gel Extraction Kit (Qiagen,) and 121 
sequenced by Sanger using an ABI Prism 3130 genetic analyser (Applied Biosystems).  122 
 123 
Preparation of RT-PCR templates for NGS analysis 124 
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Whole-genome PV RT-PCR fragments were amplified from purified RNAs from infected 125 
cells by one-step RT-PCR as described [20]. In addition, RT-PCR products were also 126 
generated by Sequence-Independent Single-Primer amplification (SISPA) of purified RNAs 127 
as described elsewhere [18, 19, 26]. Two primer sets were used to generate two different 128 
dsDNA templates from each sample. Details of primers used and amplification conditions are 129 
provided in the Supplementary Data section. 130 
 131 
Generation of sequencing libraries and quality trimming of NGS reads  132 
Sequencing libraries were prepared using Nextera XT reagents and sequenced on a MiSeq 133 
using a 2 x 301 paired-end v3 Flow Cell and manufacturer’s protocols (Illumina). Raw 134 
sequence data were imported into Geneious R10 software (Biomatters) and sequence files 135 
processed using a custom workflow. Parameters used for quality trimming of NGS reads are 136 
available in the Supplementary Data section. Raw fastq files are available from NCBI’s 137 
Sequence Read Archive (SRA) under project code PRJNA417977. 138 
 139 
Generation of polio and non-polio HEV sequence contigs from NGS data by reference-140 
guided or de novo assembly of filtered NGS reads 141 
The filtered reads were mapped to a set of HEV sequences using a curated HEV sequence 142 
database and contig sequences were generated.  Filtered reads were then iteratively 143 
reassembled to consensus sequences from the longest contigs with an aim to build whole-144 
genome contig sequences. Final consensus sequences were obtained by assigning the most 145 
common nucleotide sequence at each nucleotide position. The filtered reads were also 146 
independently assembled de novo using similar assembly conditions. Whole-genome contig 147 
sequences were generated following the same analysis workflow as above. As a result, we 148 
obtained nearly whole-genome nucleotide sequences for various HEV strains in each sample, 149 
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including various PV strains. Results using the two different assembly approaches were 150 
almost identical. Manual analyses for visualizing and quantifying assembly results were 151 
performed throughout the process. Full details regarding settings used for genome assembly 152 
are provided in the Supplementary Data section. Consensus nucleotide sequences are 153 
available from DDBJ/EMBL/GenBank with accession numbers MG451802 to MG451811 154 
 155 
Phylogenetic analysis of polio and non-polio HEV isolates  156 
The closest virus relatives to the London sewage HEV isolates were identified using the 157 
RIVM and BLAST online sequence analysis tools [27, 28] and HEV serotypes were assigned 158 
on the basis of their VP1 sequence. Whole genome PV sequences were aligned to type 1 159 
Sabin PV AY184219 or type 3 Sabin PV AY184221 reference genome sequences using the 160 
program ClustalW (within Geneious) to identify mutations and/or recombination events. Any 161 
PV3/PV1 recombinant genomic structure was confirmed by  independently mapping filtered 162 
reads to the PV1 and PV3 Sabin reference sequences mentioned above, with a minimum 50 163 
base overlap, minimum overlap identity of 95%, maximum 5% mismatches per read and both 164 
end pair reads mapping. Percentages of maximum coverage were calculated. Mapped reads 165 
against each reference were combined in a graph for each NGS product.  166 
 167 
RESULTS 168 
Concentration of sewage samples and virus isolation in cell cultures 169 
Twelve samples from London sewage were analysed. 500 ml and 120 ml of raw sewage from 170 
each sample were used for the TP and FC methods, respectively. Typically, 10 ml and 4 ml 171 
were obtained using each of the concentration procedures, which means approximate 172 
concentration factors of 50 and 30 times, respectively. Aliquot samples of sewage 173 
concentrates were used to infect RD and L20B cells. Sewage concentrates from all 12 174 
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samples produced cytopathic effect (CPE) in RD cells after 3-4 days. Only two samples, from 175 
September 2016 and January 2017, produced CPE in L20B cells. As shown in Table 1, 176 
concentrates from both sewage samples, obtained with both concentration methods produced 177 
CPE in L20B cells but only in a proportion of flasks, 5 out of 10 flasks with concentrates 178 
from September 2016 and 2 out of 12 flasks with concentrates from January 2017.  179 
 180 
Typing of PV isolates by ITD rRT-PCR and VP1 sequencing 181 
PV strains present in L20B cell cultures showing CPE were initially characterized by ITD 182 
rRT-PCR. As shown in Table 1, all PV isolates from September 2016 were identified as PV3 183 
and Sabin (vaccine)-Like (SL). The sewage sample from January 2017 produced both PV1 184 
and PV3 isolates. The TP-RD isolate from January 2017 was characterised as a PV3-SL 185 
strain while the FC-L20B1 isolate was found to be a PV1-SL strain. The PV serotype and SL 186 
classification were confirmed by nucleotide sequencing of the VP1 coding region. PV 187 
isolates showed very few VP1 mutations from Sabin references (Table 1). 188 
 189 
Genetic characterization of PV isolates by NGS 190 
The genomes of the seven selected PV isolates were further characterized by high resolution 191 
sequencing. Whole-genome PV RT-PCR products were obtained and analysed by NGS. 192 
Consensus sequences for each of the PV isolates were generated by de novo assembly. As 193 
shown in Table 2, all five isolates from September 2016 were confirmed as PV3-SL by NGS 194 
analysis, very closely related to the Sabin 3 vaccine strain and containing reversions at known 195 
Sabin 3 attenuation sites, nucleotide 472 in the 5’NCR and nucleotide 2493 coding for capsid 196 
amino acid VP1-6. Few additional nucleotide differences from Sabin 3 were found in the PV 197 
isolates, all showing unique sequences. The TP-RD PV isolate from the 2017 sample was 198 
also a PV3-SL strain and also contained reversions at nucleotides 472 and 2493. However, 199 
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the whole-genome consensus sequence of this 2017 isolate revealed a type 3/type 1 PV 200 
recombinant structure with a crossover point between nucleotides 4904 and 4914. As shown 201 
in Fig. 1, NGS reads from this isolate mapped to both Sabin 1 and Sabin 3 reference 202 
sequences in different regions of the genome. This finding was reproducible using the 203 
random PCR sequencing approach discussed in next section (Fig. 1). Finally, the 2017 L20B 204 
isolate from the FC concentrate was confirmed as PV1, very closely related to the Sabin 1 205 
vaccine strain, with only one nucleotide change from the vaccine strain.  The VP1 sequences 206 
of all PV isolates determined by NGS analysis were identical to those obtained by the Sanger 207 
method  208 
 209 
Sequence analysis of HEV mixtures found in RD cells 210 
RT-PCR products generated using random primers were also analysed by NGS with an aim 211 
to sequence any other HEV strain that might be present in the infected RD cell cultures. We 212 
first analysed virus control samples (Reference strains Enterovirus 20 JV-1, Echovirus 7 213 
Wallace, Coxsackievirus B5 Faulkner and PV Sabin 1), to test and optimize our ability to 214 
detect and identify HEV mixtures. NGS reads were filtered and analysed as described in 215 
Materials and Methods. Nucleotide sequences obtained from RA01 and M13 random RT-216 
PCR products from these reference strains were almost identical except in the extreme ends 217 
where sequence coverage was low. These extreme regions were discarded from the final 218 
consensus sequence assigned to the virus. As shown in Fig. 2A, the results showed excellent 219 
coverage across most of the genome for all viruses and nearly whole-genome sequences 220 
(≥95% of the genome) were obtained for all four reference virus strains in both single and 221 
mixed samples. Sequences in these single and mixed samples were identical and highly 222 
similar (>99.8%) to the corresponding Genebank Sanger sequences (Table 3).  223 
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The same analytical process was followed for TP-RD isolates from the two London 224 
sewage samples. Six and four different HEV strains were identified in the September 2016 225 
and January 2017 samples, respectively, including PV3 strains found in both samples. Results 226 
are shown in Fig. 2 and Table 3. Again, nearly whole-genome sequences (>90% of genome) 227 
were obtained for all virus strains identified in both samples and nucleotide sequences 228 
determined by either RA01 or M13 primers were almost identical. The relative proportions of 229 
sequence reads mapping to each of the different HEV strains identified in each sample are 230 
shown in Fig. 3. There were some differences in the results for the September 2016 sample in 231 
that Echovirus 3 sequence reads were the most prevalent in sequences from the M13 RT-PCR 232 
while Coxsackievirus B3 reads showed the highest proportion when the RA01 RT-PCR 233 
product was analysed. These differences likely reflect some degree of bias in the 234 
amplification of viral genomes from some strains using different primer sets. Echovirus 7 was 235 
the most prevalent strain in the 2017 RD culture with > 92% of reads mapping to this strain. 236 
The proportion of sequence reads mapping to PV sequences was relative low, with only 237 
6.28% and 0.76% of the total number of reads mapping to PV3 sequences for the September 238 
2016 and January 2017 samples, respectively. The closest virus relatives to the London 239 
sewage non-polio HEV isolates were identified by BLAST analysis of VP1 sequences. VP1 240 
genetic similarities to related non-polio HEV strains ranged between 87.4% to 96.9 % for 241 
nucleotides and 97.9% to 100% for amino acid sequences, confirming the HEV serotype 242 
assignment (Table 3). Two different Echovirus 7 strains were found in the September 2016 243 
sewage sample with 83.4% and 98.2% nucleotide and amino acid sequence identity between 244 
them across the whole genome, respectively.  245 
 246 
DISCUSSION 247 
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All twelve sewage samples from London (UK), tested as part of a pilot ES study, were 248 
positive for HEVs and two of them contained PV.  Type 1 and 3 vaccine-like PV isolates 249 
were found in samples taken in September 2016 and January 2017. Both concentration 250 
methods used resulted in PV isolation and we found the FC method to be simpler, quicker, 251 
less technically demanding and free from bacterial contamination as compared to the TP 252 
separation system used in most WHO laboratories. Finding PV in these samples was rather 253 
unexpected as the UK has exclusively used IPV for polio immunisation since 2004 [29]. 254 
However, vaccine-like PVs have occasionally been found in environmental samples collected 255 
in countries using only IPV, presumably imported by people coming from countries where 256 
OPV is still used [30]. The London sewage sampling site serves areas that include large 257 
migrant groups from countries where there is still OPV use.  258 
Nearly whole-genome viral sequences were rapidly generated by NGS analysis of 259 
RT-PCR products obtained using random or PV-specific primers. Five different vaccine-like 260 
PV3 strains were identified in the 2016 sewage sample, all containing few mutations from 261 
PV3 Sabin vaccine strain. These included reversions at attenuation mutations at nucleotides 262 
472 in domain V of the 5’NCR, with a role in protein translation, and 2493 coding for amino 263 
acid VP1-6 and possibly involved in virus particle stability [31, 32]. A different PV3 strain 264 
was found in the 2017 sewage sample also containing few mutations from Sabin 3 and the 265 
two reversion mutations mentioned above. This 2017 PV3 isolate had a PV3/PV1 266 
recombinant genomic structure with a crossover point locating in the region coding for non-267 
structural protein 2C.  In addition, a PV1 vaccine-like isolate with a single mutation from the 268 
Sabin 1 vaccine strain was also found in the sewage sample from 2017. The fact that all PV 269 
isolates from sewage contained a very low number of mutations from the Sabin vaccine 270 
strains indicates a very short period of replication/transmission in humans, from several days 271 
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to few weeks after vaccination, with these PV strains possibly having been excreted by just 272 
one or few recent vaccinees and/or their immediate contacts.   273 
It is striking that significant sequence differences were found between virus isolates 274 
found in the same sewage sample, including the presence of unique PV3 genetic variants in 275 
the sample from September 2016 and a PV1 strain together with a PV3/PV1 recombinant 276 
virus in the sample from January 2017. This is likely due to PV being in very low 277 
concentration in sewage leading to a strong sampling effect that is reflected when using 278 
different aliquots of concentrate to infect different cell culture flasks. This is in agreement 279 
with the fact that only a proportion of L20B cell culture flasks incubated with sewage 280 
concentrates showed CPE. Indeed, complex virus mixtures are commonly found in sewage 281 
samples, with parallel cell culture flasks infected with aliquots of the same sewage 282 
concentrate producing very different results. This might include PV in different homotypic 283 
and/or heterotypic mixtures often in combination with non-polio HEVs [6]. Furthermore, it is 284 
not at all unexpected that vaccinees excrete virus mixtures containing mixed serotype and 285 
recombinant variants [20, 33]. PV3/PV1 recombinant strains similar to the 2017 isolate found 286 
in this study are commonly found in stool samples from vaccinees taken soon after 287 
vaccination in combination with other non-recombinant and recombinant variants from all 288 
serotypes present in the OPV vaccine [33, 34].  289 
Considering that there is no OPV use in the UK and this sewage site covers a 290 
population of more than 3.5 million people, we conclude that our ES set up is sensitive 291 
enough to detect low concentrations of PV. In this context, it is expected that, should 292 
transmission of WPV1 or cVDPV2 occur in the UK following importation, it would be 293 
readily detected using our system. Importantly, no such PV isolates were detected in the 294 
London samples. It is also reassuring that no PV2 vaccine sequences were detected in any of 295 
the PV isolates identified since the type 2 component was removed from OPV in August 296 
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2016. The results shown here are compatible with the viruses found being derived from 297 
vaccinees that received type 1 and 3 bOPV.  298 
It is also expected that several non-polio HEV strains would be present in sewage 299 
concentrates, and hence in RD cultures from them, reflecting their circulation in human 300 
populations. Using NGS analysis we found 5 and 3 non-polio HEV strains of different 301 
serotypes, in addition to PV, in the London sewage samples from September 2016 and 302 
January 2017, respectively. A recent report, also using NGS, described the presence of 303 
Coxsackievirus B1, B3 and B5 strains in single RD cultures from sewage samples in Pakistan 304 
[17]. All non-polio HEV strains found in the 2016 and 2017 London samples correspond to 305 
species B HEV serotypes, a common finding that, rather than reflecting the actual prevalence 306 
of HEV serotypes in human populations, might be a consequence of the high sensitivity of 307 
RD cells for infection with species B HEVs [35]. Virus strains from all four HEV species can 308 
infect RD cells as shown by the analysis of stool extracts from AFP cases [36]. However, the 309 
complex HEV composition in sewage means that species B HEVs would likely outcompete 310 
viruses from other species when growing on RD cells. Indeed, some studies have shown that 311 
HEV strains from all four species A, B, C and D are frequently found in stool and sewage 312 
samples [7, 30, 37, 38]. Identifying them has required the use of several cell culture systems 313 
and/or sequencing RT-PCR products from multiple PCR reactions or from a large number of 314 
cDNA clones. Our NGS approach can reveal the presence of several non-polio HEV strains 315 
in a single cell culture system providing nearly whole-genome nucleotide sequence 316 
information of each of them. 317 
PV strains are known to replicate efficiently on RD cells but RD infected cultures 318 
from the two London samples were found to contain only a low proportion of PV relative to 319 
other species B non-polio HEV strains. This observation highlights the relevance of using 320 
L20B cells to increase the sensitivity for PV detection in clinical and environmental samples. 321 
 13 
 
Several studies have described the microbiome in stool and sewage samples but information 322 
on HEV content is very limited. Our results show the great value of using NGS technology 323 
for HEV surveillance, particularly for PV, as it can detect low concentrations of PV possibly 324 
excreted by one or few individuals and can quickly provide whole-genome genetic 325 
information including evidence for recombination events. Identifying genetic features that 326 
link PV isolates is essential to establish temporal and geographical relationships between 327 
them that help tracing virus transmission. Previous work in our laboratory using NGS for the 328 
analysis of both vaccine products and isolates from vaccinees has shown that these methods 329 
can also accurately identify PV strains in homotypic and heterotypic mixtures [18, 20], a 330 
critical feature that will help identifying wild PV and cVDPV strains in a background of 331 
OPV.  The use of NGS methods for HEV identification and characterisation represents a 332 
major step forward in HEV molecular diagnosis and will greatly contribute to improve our 333 
knowledge on HEV circulation patterns in human populations and their association with 334 
human disease. 335 
 336 
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Figure legends 347 
Figure 1. Coverage of Sabin PV 1 and 3 genomes following RT-PCR and sequencing by 348 
NGS of the TP-RD PV isolate from the January 2017 sewage sample. Filtered reads from 349 
(A) PV-specific, (B) M13-random or (C) RA01-random RT-PCR products obtained from 350 
RNA purified from infected cells were independently mapped against type 1 Sabin PV 351 
AY184219 (red line) or type 3 Sabin PV AY184221 (blue line) reference genome sequences. 352 
Mapped reads against each reference were combined in the graph for each NGS product. 353 
Percentages of maximum coverage are reported. The results were identical for all RT-PCR 354 
products and identified a type 3/type 1 PV recombinant with a crossover point between 355 
nucleotides 4904 and 4914.  356 
 357 
Figure 2. Genome coverage of HEV genomes following RT-PCR and sequencing by 358 
NGS of TP-RD isolates from sewage samples. Filtered reads from the virus control mixture 359 
(A, B), sewage sample from September 2016 (C, D) and sewage sample from January 2017 360 
(E, F) were mapped to the respective final HEV consensus sequences identified by de novo 361 
assembly. Results obtained with NGS reads generated with M13-random (A, C, E) and 362 
RA01-random  (B, D, F) RT-PCR products are shown. The number of sequence reads at each 363 
nucleotide position is shown for each HEV strain. The results show excellent coverage across 364 
most of the genome for all viruses. 365 
  366 
Figure 3. Percentage of filtered reads mapping to VP1 sequences.  Filtered reads from the 367 
virus control mixture (A, B), sewage sample from September 2016 (C, D) and sewage sample 368 
from January 2017 (E, F) were mapped to VP1 consensus sequences of each of the HEV 369 
strains identified by de novo assembly. Results for M13-random (A, C, E) and RA01-random 370 
(B, D, F) RT-PCR products are shown. Percentages of total reads mapping to each of the 371 
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HEV VP1 sequences are indicated. No HEV isolates were identified in any of the negative 372 
controls analysed. The results show that the proportion of PV sequences found in infected RD 373 
cells was low, particularly in the sample from January 2017. 374 
  375 
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